Valuation Transgene

Stocks

Market Closed - Euronext Paris Other stock markets 18:55:00 28/07/2026 +03			5-day change	1st Jan Change
0.7180 ^EUR	-0.42%		-1.91%	-25.21%

06-29	Transgene SA - Special Call
06-25	Oddo BHF Stays Positive on Transgene

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	247.8	164.8	137.8	89.75	262.9	196.6	-	-
Change	-	-33.52%	-16.38%	-34.86%	192.89%	-25.19%	-	-
Enterprise Value (EV) ¹	214.9	151.4	139.4	83.48	153.1	127.4	188.9	215.2
Change	-	-29.53%	-7.95%	-40.12%	83.37%	-16.74%	48.26%	13.92%
P/E	-12.1x	-5.02x	-6.23x	-2.34x	-3.69x	-5.13x	-3.26x	-7.98x
PBR	3.69x	4.38x	8.82x	5.92x	1.14x	2.39x	8.98x	-71.8x
PEG	-	-0.1x	0.2x	-0.1x	0.4x	0.1x	-0.1x	0.1x
Capitalization / Revenue	14.2x	15.9x	17.4x	14.1x	36.5x	27.3x	27.3x	3.44x
EV / Revenue	12.3x	14.6x	17.6x	13.1x	21.2x	17.7x	26.2x	3.76x
EV / EBITDA	-10.2x	-5.37x	-4.9x	-2.43x	-4.54x	-2.92x	-2.7x	-9.12x
EV / EBIT	-9.14x	-5.06x	-4.64x	-2.34x	-4.37x	-2.88x	-2.67x	-7.35x
EV / FCF	-6.59x	-6.94x	-1,408x	-3.12x	-1.07x	-3.21x	-3.13x	-8.58x
FCF Yield	-15.2%	-14.4%	-0.07%	-32%	-93.4%	-31.2%	-32%	-11.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.21	-0.33	-0.22	-0.29	-0.26	-0.14	-0.22	-0.09
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	17.41	10.34	7.9	6.353	7.21	7.2	7.2	57.2
EBITDA ¹	-21	-28.22	-28.48	-34.38	-33.73	-43.6	-70.1	-23.6
EBIT ¹	-23.52	-29.9	-30.05	-35.66	-35.06	-44.3	-70.8	-29.3
Net income ¹	-19.54	-32.8	-22.33	-33.97	-37.52	-38.2	-61.6	-25.3
Net Debt ¹	-32.93	-13.31	1.629	-6.274	-109.8	-69.2	-7.7	18.6
Reference price ²	2.5400	1.6580	1.3700	0.6800	0.9600	0.7180	0.7180	0.7180
Nbr of stocks (in thousands)	97,576	99,370	100,566	131,990	273,827	273,882	-	-
Announcement Date	3/16/22 A	3/16/23 A	3/27/24 A	3/27/25 A	3/24/26 A	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TRANSGENE	-5.13x	17.7x	-2.92x	-	224M
ARGENX SE	32.44x	8.02x	24.72x	0.05%	55.01B
WUXI APPTEC CO., LTD.	20.35x	6.27x	13.72x	1.56%	54.24B
BIONTECH SE	-18.46x	4.46x	-7.81x	-.--%	23.38B
INSMED INCORPORATED	-40.77x	12.94x	-38.12x	-.--%	22.57B
WUXI BIOLOGICS (CAYMAN) INC.	25.4x	4.97x	13.15x	-.--%	20.19B
GENMAB A/S	24.92x	4.83x	15.71x	-.--%	17.86B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-778.79x	36.99x	-4163.86x	-.--%	15.5B
PHARMAESSENTIA CORPORATION	42.81x	17.28x	44.49x	0.09%	14.2B
EXELIXIS, INC.	17.78x	5.16x	12.03x	-.--%	14.2B
Average	-67.94x	11.86x	-408.89x	0.19%	23.74B
Weighted average by Cap.	-36.73x	9.52x	-261.75x	0.37%